VKVidushi Kulshrestha

Vidushi Kulshrestha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vidushi Kulshrestha has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Accessory Cavitating Uterine Masses/Malformation: An Important Differential in Women With Intractable Dysmenorrhea and Chronic Pelvic Pain Across All Ages

    by Richa Vatsa, Soniya Dhiman, Vidushi Kulshrestha, Juhi Bharti, Neena Malhotra

    Aim: Accessory cavitated uterine malformation or mass (ACUM) is a rare and under‐recognized cause of dysmenorrhea and chronic pelvic pain (CPP). Various diagnostic criteria have been proposed; patients may present with atypical features. This study aimed to describe the clinical presentation, diagnostic challenges, and management outcomes of ACUM. Methods: Retrospective analysis of prospectively collected data was done at a tertiary care institution over 6 years. All women diagnosed with ACUM were included. Clinical presentation, imaging, preoperative diagnosis, intraoperative picture, and management outcomes were analyzed. Result: Eighteen women were enrolled. The median age at presentation was 26.5 years (18–46), with 17 in the reproductive age group and one postmenopausal. The median duration of symptoms was 4 years (2 months to 11 years). Dysmenorrhea with prominent pain on one side, localized to the side of the lesion, was the predominant symptom, occurring in 17/18 (94.4%). Of these, 10/18 (55.6%) experienced both CPP and dysmenorrhea, 7/18 (38.9%) had only dysmenorrhea. Only CPP was reported in 1/18 (5.6%), woman with postmenopausal ACUM. On initial 2D‐USG, one case was correctly diagnosed, while 5/18(27.8%) were misdiagnosed as rudimentary horn, 7/18(38.9%) as degenerated fibroid, 4/18(22.2%) as endometrioma, and 1/18(5.6%) as dermoid cyst. Diagnosis was confirmed on further imaging with 3D‐USG or MRI in 11/18 (61.1%) cases. Seventeen women underwent surgical management, with 16/17 had excision, and one postmenopausal woman was treated by laparoscopic aspiration. Conclusion: ACUM is an important differential of intractable dysmenorrhea or CPP, especially if pain is localized to either side, even in postmenopausal females.

  • Open Access

    Primary Ewing sarcoma of the uterine cervix: a case report and comprehensive review

    by Suday Halder, Seema Singhal, Sandeep Mathur, Sameer Bakhshi, Rambha Pandey, Vidushi Kulshrestha, Ekta Dhamija, Neena Malhotra

    Primary Ewing sarcoma of the uterine cervix is an exceptionally rare and aggressive malignancy, with only 34 cases reported in the literature. Early recognition and prompt multimodal treatment are essential due to its poor prognosis. We report a case involving a 32-year-old multiparous woman who presented with foul-smelling vaginal discharge and irregular bleeding. Clinical examination revealed a 6×6 cm friable cervical mass extending into the upper vagina. Imaging demonstrated an FDG-avid cervical mass with regional lymphadenopathy. Histopathological analysis, supported by immunohistochemistry and fluorescence in situ hybridization, confirmed Ewing sarcoma with EWSR1 gene rearrangement. The patient received neoadjuvant chemotherapy with VDC (vincristine, doxorubicin, cyclophosphamide) and PIE (cisplatin, ifosfamide, etoposide) regimens, followed by surgical resection, adjuvant chemotherapy, and pelvic radiotherapy. Although initial disease control was achieved, the patient experienced disease recurrence with distant metastases after a 7-month disease-free interval and succumbed to the illness 9 months after diagnosis. This case underscores the importance of including Ewing sarcoma in the differential diagnosis of rapidly growing cervical tumors, particularly in young women. A multidisciplinary approach involving early molecular diagnostics and aggressive combined therapy is critical to improving clinical outcomes in such rare and aggressive cases.


  • Pregnancy Outcomes in Women with Complete Heart Block: Experience from a Tertiary Care Hospital

    by Richa Vatsa, Ranjana Puleria, Vidushi Kulshrestha, Ajisha Aravindan, Soniya Dhiman, K. Aparna Sharma, Vatsla Dadhwal

    Background Pregnancy in women with complete heart block (CHB) poses a substantial challenge. We share our experience of managing pregnancies in patients with CHB. Methods In this case series, outcome of 12 pregnancies in 10 women with PPM is studied. The presentation, need for pacemaker, and cardiac intervention were noted in patients with CHB. Mode of delivery, obstetric complications, and neonatal outcomes were compared with 24 low-risk pregnancies. Data analysis was carried out using SPSS software. Results Syncope was presenting symptoms in seven (70%) women. Three women (30%) presented for first time during pregnancy. Out of 12 pregnancies in 10 women, eight pregnancies in six patients had a permanent pacemaker (PPM) from the start of pregnancy. Among rest four patients without a PPM, two (50%) needed pacing, one needed PPM in the second trimester, and one had a temporary pacemaker implantation (TPI) at the time of delivery. Obstetric complications and period of gestation were similar between cases and controls. The cesarean delivery rate was higher in patients with CHB, but the difference was not significant (75% vs. 37.5%, p = 0.07). None of the patients needed intensive care unit care. Mean birth weight was lower among cases (2443 ± 442 g vs. 3167 ± 434 g), but the incidence of fetal growth restriction was not different between cases and controls. Conclusion Pregnancy in patients without PPM can be safely managed without pacing, with good obstetric and neonatal outcomes. Backup for TPI and/or cardiac interventions should be available during labor.

  • Massive haemoperitoneum from an unidentified source in a woman with vWD

    by Richa Vatsa, Vidushi Kulshrestha, Neena Malhotra, Soniya Dhiman

    Von Willebrand’s disease (vWD) is an inherited coagulopathy. In women, this condition can present as periovulatory intra-abdominal bleeding or bleeding from the corpus luteum. A diagnosed case of vWD presented as an emergency with nausea, acute abdominal pain and dizziness. There was no history of amenorrhoea, abdominal trauma or bleeding from any other site. Urine pregnancy test was negative. Intra-abdominal bleeding was suspected as her repeat blood counts showed progressive fall in haemoglobin. Emergency laparoscopy was performed with provisional diagnosis of a ruptured ovarian cyst, which confirmed haemoperitoneum. However, both ovaries were normal and no bleeder was identified despite thorough intraoperative exploration. This case highlights that Von Willebrand factor replacement may suffice as the treatment even if the cause of haemorrhage remains unidentified in vWD. The challenges of undertaking surgery in patients with coagulopathy and perioperative management are discussed.


  • Bariatric Surgery during Undiagnosed Early Pregnancy: Challenges and Outcome

    by Neena Malhotra, Saloni Kamboj, Soni Bharti, Richa Vatsa, Riya Bagdi, Vidushi Kulshrestha

  • Cytokines and Pentraxin 3 Levels in Unexplained Recurrent Pregnancy Loss: Role of Oral Micronized Progesterone Therapy as Immunomodulator on Their Levels and Pregnancy Outcome, a Prospective Comparative Study

    by Nutan Agarwal, Stuti Gupta, Vidushi Kulshrestha, Raj Kumar Yadav, Alka Kriplani, Garima Kachhawa, Neerja Bhatla

    Objective To assess cytokines(TNFα, IL6) and pentraxin3(PTX3) in unexplained recurrent pregnancy loss(RPL) compared to controls and to evaluate immunomodulatory effect of oral micronized progesterone. Methods This prospective comparative trial was conducted in 90 pregnant females: 60 RPL(group-1) and 30 controls(group-2). Group-1 was randomized into group-1a (n = 30) receiving oral micronized progesterone 200 mg twice daily and group-1b (n = 30) not receiving progesterone. TNFα(Th1-cytokine), IL6(Th2-cytokine) and PTX3 were measured at baseline(< 8 weeks), 16 weeks and at abortion/delivery. Results In all three groups, baseline TNFα, IL6 and PTX3 were similar; and levels increased as pregnancy advanced. However, progesterone modulated the rise favorably in group-1a, which was similar to controls (group-2). A significant rise at 16 weeks was noted for TNFα in group-1b (p = 0.0002); IL6 in group-1a (p = 0.0001) and group-2 (p = 0.04); and PTx3 in group-1b (p = 0.028); number of previous abortions not affecting rise. The abortion rate was 3.5% vs. 16.7% in group-1a and 1b, respectively. No patient aborted if baseline TNFα was < 6.5 pg/ml and PTx3 was < 3441 pg/ml. Conclusion Favorable shift in TNFα, IL6 and PTx3 levels with oral micronized progesterone appears to exert immunomodulatory effect that support pregnancy continuation in RPL. Baseline TNFα < 6.5 pg/ml and PTx3 < 3441 pg/ml have good pregnancy outcome even without progesterone support. Women with higher levels than these can be offered progesterone therapy. Trial registration Clinical trial registry of India (CTRI/2016/09/007278).


  • Open Access

    Severe Burns in Pregnancy: Challenges Faced!

    by Vidushi Kulshrestha, Saloni Kamboj, Nilanchali Singh

  • Imaging features of accessory cavitated uterine mass (ACUM): a peculiar yet correctable cause of dysmenorrhea

    by Shivani Gupta, Smita Manchanda, Surabhi Vyas, Neena Malhotra, Sandeep R. Mathur, Vidushi Kulshrestha

    Accessory cavitated uterine mass (ACUM) is a rare form of developmental mullerian anomaly which causes chronic pelvic pain, dysmenorrhea and infertility in young females. It is a non-communicating, accessory cavity within an otherwise normal uterus, lined by functional endometrium and surrounded by myometrium-like smooth muscle cells which imparts it uterus-like appearance. USG and MRI are the imaging modalities which help in reaching the diagnosis. Knowledge of this entity and awareness of its imaging features can help diagnose this often underdiagnosed and surgically correctable cause of dysmenorrhea. Graphical abstract


  • Open Access

    Outcome in women undergoing uterine artery embolization for arterio-venous malformation diagnosed post-pregnancy-A retrospective study

    by Vidushi Kulshrestha, Swati Shivhare, Jyoti Meena, Shivanand Gamanagatti, Seema Singhal, Neeta Singh, Sunesh Kumar, Vatsla Dadhwal

    Objective: To analyse the outcome of patients with symptomatic arterio-venous malformation (AVM), formed following pregnancy and managed by uterine artery embolization (UAE). Materials and Methods: This retrospective study was conducted after ethical approval and included 15 patients presenting with abnormal uterine bleeding following pregnancy, who were suspected to have an AVM which later was confirmed by angiography and managed with UAE. Presenting symptoms, postUAE complications and subsequent fertility outcomes were noted. Follow-up period ranged from 6 months to 2.5 years. Results: The mean age was 28.4 +/- 3.82 years and mean parity was 1.3. Out of 15 cases, 9 (60%) presented after abortion, 4 (26.6%) after normal vaginal delivery and 2 (13.3%) after cesarean delivery; of these 10/15 (66.7%) patients had a history of curettage. The most common presenting symptom was continuous bleeding per-vaginum since the antecedent pregnancy in 9/15 (60%) patients and 6/15 (40%) patients had irregular bleeding. The mean duration of symptoms was 91 +/- 85.7 (30-360) days. For UAE, embolic agents used were polyvinyl alcohol (PVA) particles (300-500 mu m) in 2 (13.3%), 30% glue injection in 3 (20%), the combination of PVA with glue injection in 4 (26.6%) and PVA with gelfoam in 6 (40%) patients. After UAE, bleeding responded within 3.6 +/- 0.97 (3-6) days in all but one patient who required repeat UAE one month later. All women resumed their normal menstrual cycle in 31.3 +/- 5.2 (24-42) days. Ten patients desired conception, of whom 5 (50%) conceived within 13.2 +/- 5.1 (6-19) months after UAE. Two women carried pregnancy to term, one underwent preterm cesarean for growth restriction with oligohydramnios. One patient had postpartum hemorrhage, which was managed medically. One had spontaneous abortion at 6 weeks gestation and the other is 13 weeks pregnant at present. Conclusion: UAE is an effective treatment modality for the management of symptomatic post-pregnancy AVMs.


  • Open Access

    Use of ‘Printed Investigation Sheet’ as Checklist in Admitted Antenatal Patients: A Quality Improvement Initiative

    by Vidushi Kulshrestha, Anubhuti Rana, Kamlesh Kumari, Jyoti Meena, K Aparna Sharma, Vatsla Dadhwal, Sunesh Kumar

    Background The study was conducted to establish use of printed investigation sheets as checklists for timely workup and clinical evaluation of antenatal women with medical diseases; admitted in maternity ward, by third day of their hospital admission. This was aimed to standardize care, avoid repeated blood sampling of patients, avoid delay in starting the treatment and help teams perform optimally by systematic use of quality improvement (QI) tools. Methods The present study was conducted in the Department of Obstetrics and Gynaecology at a tertiary care teaching hospital using point-of-care quality improvement methodology systematically. A QI team was made who formulated an aim statement, conducted a root-cause analysis, performed plan-do-study-act (PDSA) cycles. The outcome was measured as complete clinical evaluation of antenatal women with anaemia, hypertension, and/or diabetes by third day of admission in the maternity ward. Results The baseline data showed that median percentage of patients with complete clinical evaluation was only 29.2%. After a root-cause analysis with fishbone tool, three PDSA cycles were conducted to achieve the target of 80%. After the third PDSA cycle, complete clinical evaluation in anaemia, hypertension, diabetes showed an improving trend with a median of 75%. Conclusion Adopting simple principles of quality improvement, initiating use of printed investigation sheets as checklist can streamline and expedite clinical evaluation of antenatal patients with medical problems so as to avoid unnecessary delay in initiating the management in busy maternity wards.